ERBB2 and ovarian cancer: Furthermore C6.5 CAR T cells directly and efficiently lysed representative HER2+ human established ovarian cancer cells (OVCAR-3) and primary human solid tumor (1513) or ascites (1742) cancer cells during an 18 hour chromium release assay.